Improving the management of pain from advanced cancer in the community
- Conditions
- Topic: CancerSubtopic: Colorectal Cancer, Upper Gastro-Intestinal Cancer, Breast Cancer, Lung Cancer, Prostate CancerDisease: Breast, Colon, Lung (non-small cell), ProstateCancer1. Colorectal Cancer 2. Upper Gastro-Intestinal Cancer 3. Breast Cancer 4. Lung Cancer 5. Prostate Cancer
- Registration Number
- ISRCTN18281271
- Lead Sponsor
- niversity of Leeds
- Brief Summary
2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29572400 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34870925/ (added 13/07/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 161
1. Aged 16 years or over
2. Diagnosis of advanced incurable disease (locally advanced or metastatic) in one of the following disease areas:
2.1. Breast
2.2. Colon or rectal
2.3. Non-small cell lung cancer
2.4. Prostate
2.5. Upper GI
3. Experiencing cancer related pain (tumour or treatment related) (as assessed by the Clinician) with an average pain score of = 4 on the average pain” item of the Brief Pain Inventory
4. Has the potential to benefit from palliative care support as assessed by the Clinician
5. An expected prognosis of 12 weeks or more
6. The patient is living at home
7. The patient lives in the local catchment area for a participating hospice
8. The patient is able and willing to provide written informed consent
1. Previously referred to palliative care team
2. The patient has insufficient literacy, or proficiency in English to contribute to the data collection required for the research
3. Patients will be excluded if they lack capacity to provide informed consent to this trial
4. Patients with dominant chronic pain that is not cancer related (tumour or treatment)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method